Fomento Economico Mexicano SAB Earnings Calls
| Release date | Apr 30, 2026 |
| EPS estimate | $0.0803 |
| EPS actual | $0.186 |
| EPS Surprise | 132.10% |
| Revenue estimate | 11.416B |
| Revenue actual | 11.713B |
| Revenue Surprise | 2.60% |
| Release date | Feb 25, 2026 |
| EPS estimate | $0.143 |
| EPS actual | $0.138 |
| EPS Surprise | -3.91% |
| Revenue estimate | 12.213B |
| Revenue actual | 12.208B |
| Revenue Surprise | -0.0354% |
| Release date | Oct 28, 2025 |
| EPS estimate | $0.116 |
| EPS actual | $0.387 |
| EPS Surprise | 234.23% |
| Revenue estimate | 11.611B |
| Revenue actual | 11.523B |
| Revenue Surprise | -0.763% |
| Release date | Jul 28, 2025 |
| EPS estimate | $0.108 |
| EPS actual | $0.0406 |
| EPS Surprise | -62.23% |
| Revenue estimate | 11.324B |
| Revenue actual | 11.341B |
| Revenue Surprise | 0.142% |
Last 4 Quarters for Fomento Economico Mexicano SAB
Below you can see how FMXUF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 28, 2025 |
| Price on release | $9.80 |
| EPS estimate | $0.108 |
| EPS actual | $0.0406 |
| EPS surprise | -62.23% |
| Date | Price |
|---|---|
| Jul 22, 2025 | $9.90 |
| Jul 23, 2025 | $9.80 |
| Jul 24, 2025 | $9.80 |
| Jul 25, 2025 | $9.80 |
| Jul 28, 2025 | $9.80 |
| Jul 29, 2025 | $9.80 |
| Jul 30, 2025 | $9.80 |
| Jul 31, 2025 | $9.80 |
| Aug 01, 2025 | $9.80 |
| 4 days before | -1.01% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | -1.01% |
| Release date | Oct 28, 2025 |
| Price on release | $9.70 |
| EPS estimate | $0.116 |
| EPS actual | $0.387 |
| EPS surprise | 234.23% |
| Date | Price |
|---|---|
| Oct 22, 2025 | $9.46 |
| Oct 23, 2025 | $9.70 |
| Oct 24, 2025 | $8.50 |
| Oct 27, 2025 | $9.70 |
| Oct 28, 2025 | $9.70 |
| Oct 29, 2025 | $9.70 |
| Oct 30, 2025 | $9.70 |
| Oct 31, 2025 | $9.41 |
| Nov 03, 2025 | $9.41 |
| 4 days before | 2.54% |
| 4 days after | -2.99% |
| On release day | 0% |
| Change in period | -0.529% |
| Release date | Feb 25, 2026 |
| Price on release | $11.00 |
| EPS estimate | $0.143 |
| EPS actual | $0.138 |
| EPS surprise | -3.91% |
| Date | Price |
|---|---|
| Feb 19, 2026 | $11.00 |
| Feb 20, 2026 | $11.00 |
| Feb 23, 2026 | $11.00 |
| Feb 24, 2026 | $11.00 |
| Feb 25, 2026 | $11.00 |
| Feb 26, 2026 | $11.00 |
| Feb 27, 2026 | $11.00 |
| Mar 02, 2026 | $11.00 |
| Mar 03, 2026 | $11.00 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Apr 30, 2026 |
| Price on release | $11.35 |
| EPS estimate | $0.0803 |
| EPS actual | $0.186 |
| EPS surprise | 132.10% |
| Date | Price |
|---|---|
| Apr 24, 2026 | $11.35 |
| Apr 27, 2026 | $11.35 |
| Apr 28, 2026 | $11.35 |
| Apr 29, 2026 | $11.35 |
| Apr 30, 2026 | $11.35 |
| May 01, 2026 | $11.35 |
| May 04, 2026 | $11.35 |
| May 05, 2026 | $11.35 |
| May 06, 2026 | $11.35 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Fomento Economico Mexicano SAB Earnings Call Transcript Summary of Q1 2026
FEMSA reported a solid start to 2026 with constructive momentum at its core proximity business and selected international operations, alongside important reporting changes. Key points for investors:
- Reporting changes: Management reorganized disclosure into five segments (OXXO Mexico; Americas & Mobility; Europe; Health; Coca‑Cola FEMSA) to improve transparency on fast‑growing operations (notably OXXO LatAm and fuel). OXXO Mexico is now reported separately.
- OXXO Mexico: Continued recovery — revenues +8.3% Y/Y, same‑store sales +6.0%, gross margin expansion (46.2%, +140 bps), operating income +20.9% and operating margin improvement to 7.6%. Traffic remains slightly negative but improved versus last year; management is focused on restoring sustained traffic growth through affordability, promotions, coffee/food, retail media and improved customer experience. Net new stores added: 158 in the quarter (company expects 900–1,100 openings this year but may prune some underperforming locations).
- Americas & Mobility: Strong growth overall (segment revenues +12.9% Y/Y; comparable & currency‑neutral +10.5%). LatAm ex‑Brazil same‑store sales were particularly strong (>20% in local currency) while Brazil is early in consolidation and currently loss‑making but improving; fuel business contributed margin tailwinds.
- Europe: Stable revenue and operating income growth driven by Swiss retail/foodservice; weak German B2B/traffic but cost discipline delivered margin improvement.
- Health: Underperforming – revenues roughly flat; margin pressure from Chile (product mix, GLP‑1s) and continued losses in Mexico. Management is reducing exposure to low‑margin institutional receivables in Colombia (notably non‑renewal with EPS Sanitas in September) and prioritizing retail drugstores.
- Coca‑Cola FEMSA: Mixed quarter — consolidated comparable revenue +6.3% and operating income +2.1% on a comparable basis; Mexico remains the more challenged market.
- Spin (fintech): Strong user traction — 11M active users and >100M monthly transactions; tender share over 50% in Q1. Management views Spin as an omnichannel driver for traffic, retail media, and future services (careful on credit initiatives).
- Financials and one‑offs: Consolidated revenues +6.1% Y/Y (currency neutral +8.5%), operating income +5.5% (currency neutral +12.1%). Net consolidated income jumped 97.3% to 17.6B CLP driven by a one‑time non‑cash accounting gain related to BradyPLUS/Imperial Dade; underlying net income excluding that gain would have declined ~36% due to FX losses, valuation swings and lower interest income. Effective tax rate ex‑one‑offs would be ~37.9%.
- Capital allocation: Q1 CapEx 6.2B pesos (~3% of revenues); expect CapEx to accelerate and trend toward 5–6% of sales through the year. Shareholder returns: ordinary dividend of 15.2B pesos (Mar 2026–Mar 2027), extraordinary dividend ~25.8B pesos, total distributions ~41B pesos, plus ongoing 300M‑share buyback (expected to complete in Q2). Management expects to finish the year around or slightly below a 2x net debt/EBITDA target, with flexibility via buybacks, extraordinary dividends or M&A.
- Risks & outlook: Continued macro uncertainty, currency/headwinds (stronger MXN), Health segment execution and the timing of margin reversions from commercial income. Management is optimistic for near‑term catalysts (World Cup, retail media, Spin) but cautious on H2 macro volatility.
Sign In
Buy FMXUF